These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 19756021)
1. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. Weinstein JS; Varallyay CG; Dosa E; Gahramanov S; Hamilton B; Rooney WD; Muldoon LL; Neuwelt EA J Cereb Blood Flow Metab; 2010 Jan; 30(1):15-35. PubMed ID: 19756021 [TBL] [Abstract][Full Text] [Related]
2. Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL. Farrell BT; Hamilton BE; Dósa E; Rimely E; Nasseri M; Gahramanov S; Lacy CA; Frenkel EP; Doolittle ND; Jacobs PM; Neuwelt EA Neurology; 2013 Jul; 81(3):256-63. PubMed ID: 23771486 [TBL] [Abstract][Full Text] [Related]
3. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Stoll G; Bendszus M Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996 [TBL] [Abstract][Full Text] [Related]
4. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Corot C; Petry KG; Trivedi R; Saleh A; Jonkmanns C; Le Bas JF; Blezer E; Rausch M; Brochet B; Foster-Gareau P; Balériaux D; Gaillard S; Dousset V Invest Radiol; 2004 Oct; 39(10):619-25. PubMed ID: 15377941 [TBL] [Abstract][Full Text] [Related]
5. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies. Deddens LH; Van Tilborg GA; Mulder WJ; De Vries HE; Dijkhuizen RM Cerebrovasc Dis; 2012; 33(4):392-402. PubMed ID: 22456323 [TBL] [Abstract][Full Text] [Related]
6. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. Israel LL; Galstyan A; Holler E; Ljubimova JY J Control Release; 2020 Apr; 320():45-62. PubMed ID: 31923537 [TBL] [Abstract][Full Text] [Related]
7. USPIO-Enhanced MRI Neuroimaging: A Review. Gkagkanasiou M; Ploussi A; Gazouli M; Efstathopoulos EP J Neuroimaging; 2016; 26(2):161-8. PubMed ID: 26932522 [TBL] [Abstract][Full Text] [Related]
8. Superparamagnetic iron oxide nanoparticles (SPIONs): synthesis and surface modification techniques for use with MRI and other biomedical applications. Yoffe S; Leshuk T; Everett P; Gu F Curr Pharm Des; 2013; 19(3):493-509. PubMed ID: 22934920 [TBL] [Abstract][Full Text] [Related]
9. Imaging pathobiology of carotid atherosclerosis with ultrasmall superparamagnetic particles of iron oxide: an update. Sadat U; Usman A; Gillard JH Curr Opin Cardiol; 2017 Jul; 32(4):437-440. PubMed ID: 28463893 [TBL] [Abstract][Full Text] [Related]
10. [Contrast agents in MRI-diagnosis of multiple sclerosis]. Abakumova TO; Nukolova NV; Gusev EI; Chekhonin VP Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):58-65. PubMed ID: 25909791 [TBL] [Abstract][Full Text] [Related]
11. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. Lartigue L; Hugounenq P; Alloyeau D; Clarke SP; Lévy M; Bacri JC; Bazzi R; Brougham DF; Wilhelm C; Gazeau F ACS Nano; 2012 Dec; 6(12):10935-49. PubMed ID: 23167525 [TBL] [Abstract][Full Text] [Related]
12. Magnetic iron oxide nanoparticles for biomedical applications. Laurent S; Bridot JL; Elst LV; Muller RN Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176 [TBL] [Abstract][Full Text] [Related]
13. Flame synthesis and in vitro biocompatibility assessment of superparamagnetic iron oxide nanoparticles: cellular uptake, toxicity and proliferation studies. Buyukhatipoglu K; Miller TA; Clyne AM J Nanosci Nanotechnol; 2009 Dec; 9(12):6834-43. PubMed ID: 19908687 [TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic iron oxide-enhanced magnetic resonance for imaging cardiac inflammation. A minireview. Podrouzkova H; Feitova V; Panovsky R; Meluzin J; Orban M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):378-81. PubMed ID: 24993740 [TBL] [Abstract][Full Text] [Related]
15. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study. Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560 [TBL] [Abstract][Full Text] [Related]
16. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. Neuwelt A; Sidhu N; Hu CA; Mlady G; Eberhardt SC; Sillerud LO AJR Am J Roentgenol; 2015 Mar; 204(3):W302-13. PubMed ID: 25714316 [TBL] [Abstract][Full Text] [Related]
17. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy. Smirnov P Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287 [TBL] [Abstract][Full Text] [Related]
18. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis. Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453 [TBL] [Abstract][Full Text] [Related]
19. RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia. Zheng SW; Huang M; Hong RY; Deng SM; Cheng LF; Gao B; Badami D J Biomater Appl; 2014 Mar; 28(7):1051-9. PubMed ID: 23796630 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Yue-Jian C; Juan T; Fei X; Jia-Bi Z; Ning G; Yi-Hua Z; Ye D; Liang G Drug Dev Ind Pharm; 2010 Oct; 36(10):1235-44. PubMed ID: 20818962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]